Christopher Seiter's most recent trade in Trevi Therapeutics Inc was a trade of 80,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 17, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Trevi Therapeutics Inc | Christopher Seiter | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 80,000 | 80,000 | - | - | Stock Option (right to buy) |